Showing results (11-20 of 151) with videos related to

Sort By:
Pageof 16
Biochimica Et Biophysica Acta|April 10, 2009
Role of B-Raf(V600E) in differentiated thyroid cancer and preclinical validation of compounds against B-Raf(V600E)Carmelo Nucera, Melanie Goldfarb, Richard Hodin, et al.
Annals of Surgical Oncology|July 20, 2011
Medical and surgical risks in thyroid surgery: lessons from the NSQIPMelanie Goldfarb, Zvi Perry, Richard A Hodin, et al.
American Journal of Surgery|July 20, 2010
Surgical implications of B-RafV600E mutation in fine-needle aspiration of thyroid nodulesMichal Mekel, Carmelo Nucera, Richard A Hodin, et al.
American Journal of Surgery|May 25, 2006
Carcinoid tumors in the breastJ Nalinee Upalakalin, Laura C Collins, Nicholas Tawa, et al.
Surgery|November 20, 2012
BRAF V600E status adds incremental value to current risk classification systems in predicting papillary thyroid carcinoma recurrenceJason D Prescott, Peter M Sadow, Richard A Hodin, et al.
The Laryngoscope|February 10, 2011
Overcoming obstacles to setting up office-based ultrasound for evaluation of thyroid and parathyroid diseasesSushruta S Nagarkatti, Michal Mekel, Robert A Sofferman, et al.
Advanced Drug Delivery Reviews|April 1, 2022
Deciphering albumin-directed drug delivery by imagingHuiyu Hu, Jeremy Quintana, Ralph Weissleder, et al.
Cancer Letters|June 8, 2006
Continuous administration of the three thrombospondin-1 type 1 repeats recombinant protein improves the potency of therapy in an orthotopic human pancreatic cancer modelXuefeng Zhang, Caitlin Connolly, Mark Duquette, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 4, 2007
Adeno-associated virus-mediated antiangiogenic gene therapy with thrombospondin-1 type 1 repeats and endostatinXuefeng Zhang, Jianfeng Xu, Jack Lawler, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 3, 2005
Antiangiogenic treatment with three thrombospondin-1 type 1 repeats versus gemcitabine in an orthotopic human pancreatic cancer modelXuefeng Zhang, Eric Galardi, Mark Duquette, et al.
Pageof 16